Oasmia Pharmaceutical AB Profit Loss From Continuing Operations
Oasmia Pharmaceutical AB reported Profit Loss From Continuing Operations of -SEK 132.16 million for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Notes
ifrs-full:ProfitLossFromContinuingOperations · last filed 2018-09-14
| Period end | Profit Loss From Continuing Operations 12 month |
|---|---|
| 2018-04-30 | -132.16M SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | -157.76M SEK 20-F · filed 2018-09-14 |
| 2016-04-30 | -155.64M SEK 20-F · filed 2018-09-14 |